Risk Factors that Impact Treatment with Oral Janus Kinase Inhibitors Among Adult Patients with Atopic Dermatitis: A Nationwide Registry Study
The European Medicines Agency recently limited the use of oral Janus kinase inhibitors in certain patient populations, including those with atopic dermatitis. This cross-sectional study used the Danish national registers and Danish Skin Cohort to assess the prevalence of risk factors that potentiall...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Medical Journals Sweden
2024-01-01
|
| 叢編: | Acta Dermato-Venereologica |
| 主題: | |
| 在線閱讀: | https://medicaljournalssweden.se/actadv/article/view/18638 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|